Bonus Material-25_MARCINIUK SEEK Session 2025 UPLOADED

Pdf Summary

This document, authored by Dr. Darcy D. Marciniuk, presents an educational review on pulmonary medicine with focus on clinical assessment, interventions, and management of various pulmonary conditions. Key topics include:

1. <strong>6-Minute Walk Test (6MWT)</strong>: A practical, safe, and responsive functional test for interstitial lung disease and other lung disorders. Two tests should be conducted at baseline because of a learning effect. The test can be performed with supplemental oxygen, but methodology must be standardized regarding oxygen use, encouragement, and testing location.

2. <strong>Long-term Nocturnal Non-invasive Ventilation (NIV) in COPD</strong>: NIV is considered for stable hypercapnic COPD patients (PaCO2 ≥46-52 mmHg), typically 2-4 weeks post-exacerbation. It improves quality of life, exercise capacity, and may reduce hospital admissions and mortality. Guidelines from ATS, ERS, and CTS support its use when carefully monitored.

3. <strong>Preoperative Risk Assessment using Cardiopulmonary Exercise Testing (CPET)</strong>: CPET is valuable for evaluating surgical risk in lung cancer patients with COPD. A peak VO2/kg >20 mL/min/kg suggests low surgical risk making lobectomy feasible without further tests like stair climb or radionuclide scans.

4. <strong>Pharmacologic Management of COPD</strong>:
   - Triple inhaled therapy with ICS/LABA/LAMA improves lung function, symptoms, quality of life, and reduces exacerbations and mortality compared to dual LABA/LAMA therapy. However, ICS use raises pneumonia risk.
   - Oral therapies such as roflumilast are indicated in patients with severe COPD exhibiting chronic bronchitis, frequent exacerbations, and FEV1 ≤50%. Azithromycin may reduce exacerbations in moderate COPD former smokers.
   - Blood eosinophil counts help guide ICS therapy escalation or withdrawal.

5. <strong>Case-based Clinical Scenarios</strong>:
   - Idiopathic Pulmonary Fibrosis (IPF): Patients with typical radiologic patterns and mild/moderate impairment benefit from antifibrotic therapy (e.g., nintedanib). Immunosuppressants like prednisone or azathioprine worsen outcomes.
   - Yellow Nail Syndrome: Characterized by pleural effusions, lymphedema, yellow nails, and bronchiectasis. It results from lymphatic dysfunction and requires conservative management; severe cases may need pleurodesis.

The text integrates current guidelines and clinical trial data, emphasizing evidence-based practice for diagnosis, intervention selection, and patient monitoring in pulmonary medicine.

Meta Tag

Concept 6-Minute Walk Test

Concept Nocturnal Non-Invasive Ventilation

Concept Chronic Obstructive Pulmonary Disease

Concept Cardiopulmonary Exercise Testing

Concept Hypercapnia

Keywords

pulmonary medicine

6-minute walk test

non-invasive ventilation

COPD management

cardiopulmonary exercise testing

triple inhaled therapy

idiopathic pulmonary fibrosis

nintedanib

blood eosinophils

yellow nail syndrome

6-Minute Walk Test

Nocturnal Non-Invasive Ventilation

Chronic Obstructive Pulmonary Disease

Cardiopulmonary Exercise Testing

Hypercapnia

COPD